NCT05633862View on ClinicalTrials.gov

A Study in Healthy Chinese People to Test How Different Doses of BI 1015550 Are Taken up in the Body

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

January 13, 2023

Primary Completion Date

March 16, 2023

Study Completion Date

March 17, 2023

Conditions
Healthy
Interventions
DRUG

BI 1015550

BI 1015550

Trial Locations (1)

100032

Peking Union Medical College Hospital, Beijing

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT05633862 - A Study in Healthy Chinese People to Test How Different Doses of BI 1015550 Are Taken up in the Body | Biotech Hunter | Biotech Hunter